Tender Offer Deutsche Balaton Biotech AG and DELPHI Unternehmensberatung AG
Deutsche Balaton Biotech AG, based in Heidelberg, Ziegelhäuser Landstraße 1, and DELPHI Unternehmensberatung AG, based in Heidelberg, Ziegelhäuser Landstraße 1, has submitted a public tender offer (“Offer”) to shareholders of Biofrontera AG to acquire up to 500,000 registered shares of Biofrontera AG with the ISIN DE0006046113.
Documents published by Deutsche Balaton Biotech AG and DELPHI Unternehmensberatung AG regarding the Offer are available on the internet https://www.deutschebalatonbiotech.de/erwerbsangebot-biofrontera-2019.
Biofrontera AG accepts no responsibility for the contents or other information available on this website.
According to Art. 27 of the German Securities Acquisition and Takeover Act (WpÜG), the Management Board and the Supervisory Board of Biofrontera AG are required to give an opinion on the Offer and any changes of the Offer.
Pursuant to Art. 27 WpÜG, employees also have the opportunity to give an opinion on the Offer.
Below you will find the opinion of the Biofrontera AG Management Board and Supervisory Board and any updates thereto, as well as the opinion of our employees: